Transcatheter Aortic Valve Implantation (TAVI)
The minimally invasive alternative for treating
severe aortic stenosis
TAVI – Returning faster to an active life
Timing is everything
Review data on the urgency to treat aortic stenosis and discover useful materials to support you.
For treatment with TAVI
Find information to identify patients who benefit from TAVI according to the ESC/EACTS AS guidelines.
A minimally invasive alternative
Watch the TAVI procedure animation to learn more about the therapy for easy patient conversations.
About aortic stenosis and treatment options
Request patient materials and find local heart valve patient organisations to share with your patients.
Summary and key considerations
Discover our summary of the latest ESC/EACTS aortic stenosis guidelines and supporting materials for you.
See the CoreValve™ Evolut™ R, the CoreValve™ Evolut™PRO and the Evolut™ PRO+ device manuals for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use at www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
The commercial name of the Evolut™ R device is Medtronic CoreValve™ Evolut™ R System, the commercial name of the Evolut™ PRO device is Medtronic CoreValve™ Evolut™ PRO System, and the commercial name of the Evolut™ PRO+ device is Medtronic Evolut™ PRO+ System.
© 2025 Medtronic. All rights reserved, Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic™.* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet. March 14, 2009;373(9667):956-966.
2. Reardon MJ. Deep Dive From the Evolut Low Risk Trial. Presented at ACC 2019; New Orleans, LA.
3. Modine T. The impact of procedural complications on recovery and quality of life after TAVI or SAVR in patients at low risk of mortality following surgery. Presented at EuroPCR 2019; Paris, France.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.